FilingsTodayCaregen
At a glance
Caregen filed 48 disclosures in the last 12 months, including 10 5% holder, 9 insider, 2 contract and 1 earnings. The most recent key filing was on Oct 1.
Revenue for 2025 was ₩72.8B, down 11.8% on 2024. Operating margin was 28% against 41.5% a year earlier. Debt was 9% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩41.5B and operating profit of ₩15.4B.
The 2025 annual report lists 201 employees with an average tenure of 4 years and average pay of ₩50.8M, #1422 of 1,829 listed companies by average pay. Its 6 directors and auditors were paid ₩364M each on average. It paid ₩437 per common share in cash dividends, against ₩640 a year earlier (-31.7%). 정용지 and related parties held 64.43% at year end.
From the 2025 annual report
Staff: 201 (120 men, 81 women), of whom 2 on fixed-term contracts. Total pay for the year: ₩10.2B. Directors and auditors: 6, paid ₩2.2B in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩437 | ₩640 | ₩640 |
| Payout ratio | 106.3% | 97% | 78.8% |
| Yield (as filed) | 0.70% | 2.30% | 2.30% |
| Total cash dividends | ₩21.4B | ₩31.3B | ₩31.4B |
Largest shareholder
정용지 holds 63.28%; with 4 related parties the group holds 64.43% of common shares at year end.
Individuals paid ₩500M or more
| 정용지 대표이사 | ₩1.7B |
Auditor: 동현회계법인 · opinion: Unqualified.
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.